PF-07242813 / Pfizer  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PF-07242813 / Pfizer
NCT04668066: Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis

Completed
1
121
US
PF-07242813, Placebo
Pfizer
Atopic Dermatitis
12/22
12/22

Download Options